compareglp-1

A comparison studio
Independent editorial information · not individual medical advice

Commercial pages may contain paid referral links. Compare the full payment terms and licensed-care details before enrollment.

Guide7 min read

503B vs 503A GLP-1 Providers: A Patient's Comparison Guide

Price verification — October 26, 2026

This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.

These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due. Compounded GLP-1 products are not FDA-approved. Their availability, lawful compounding circumstances and product claims require separate verification. FDA policy.

The FDA's 503B Bulks List proposal is making pharmacy classifications relevant to every GLP-1 patient. Here's what you need to understand.

Quick Comparison

503A Pharmacy503B Outsourcing Facility
RegulationState pharmacy boardFDA (direct)
PrescriptionPatient-specific requiredNot always needed
ScaleIndividual ordersLarge-batch permitted
FDA proposal impactNot directly targetedDirectly affected
Quality standardsUSP 795/797cGMP (pharmaceutical-grade)

Why This Matters Right Now

The FDA proposed excluding GLP-1 active ingredients from the 503B Bulks List on April 30, 2026. If finalized, 503B facilities lose the ability to compound semaglutide, tirzepatide, and liraglutide at scale. 503A pharmacies operate under different authority and aren't directly targeted by this specific proposal.

How to Find Out Your Pharmacy Type

  1. Ask your provider directly: "Is my medication compounded by a 503A or 503B pharmacy?"
  2. Check the FDA's outsourcing facility registry — 503B facilities must be listed
  3. Look for "cGMP" language — this typically indicates a 503B facility

Wellorithm · from $147/mo

Compounded medications are not FDA-approved. Paid link

Yucca Health Compounded

$146/mo sema

Try Gala GLP-1 instead → Paid link

Compounded medications are not FDA-approved.

Found Health Compounded

from $129/mo

Check Eligibility → Paid link

Compounded medications are not FDA-approved.

Sesame Care Brand-Name

brand-name Rx

Check Eligibility → Paid link

The Bottom Line

If your provider uses a 503A pharmacy, the FDA's current proposal has less immediate impact on your prescription. If they use a 503B facility, start planning for alternatives now — the regulatory timeline gives you months, not days. Either way, brand-name options at lower price points (oral Wegovy at $149) provide a safety net.

Sources

  1. FDCA Sections 503A and 503B
  2. FDA proposed rule, April 30, 2026

You May Also Like

Free Download

The GLP-1 Cost & Provider Comparison Guide

10 pages breaking down real all-in monthly costs, what drives price differences between providers, and the questions to ask before you commit.